Anti-spike antibody response to natural infection with SARS-CoV-2 and its activity against emerging variants
C.-P. Chen, K.-Y. A. Huang, S.-R. Shih, Y.-C. Lin, C.-Y. Cheng, Y.-C. Huang, T.-Y. Lin, S.-H. Cheng
This study examines spike-specific antibody responses in SARS-CoV-2 natural infections, showing waning immunity over 11 months and reduced activity against emerging variants like Beta and Omicron.
bioRxiv · Mar 7, 2022Immunology